These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22347701)

  • 1. Evolving role of pharmaceutical physicians in the industry: Indian perspective.
    Patil A; Rajadhyaksha V
    Perspect Clin Res; 2012 Jan; 3(1):35-9. PubMed ID: 22347701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving role of pharmaceutical physicians in medical evidence and education.
    Setia S; Ryan NJ; Nair PS; Ching E; Subramaniam K
    Adv Med Educ Pract; 2018; 9():777-790. PubMed ID: 30464675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
    Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
    Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An insight into the emerging role of regional medical advisor in the pharmaceutical industry.
    Gupta SK; Nayak RP
    Perspect Clin Res; 2013 Jul; 4(3):186-90. PubMed ID: 24010061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Physician Advisor's Role in Contemporary Psychiatry and Quality of Care.
    Jayaram G
    Psychiatry (Edgmont); 2006 Aug; 3(8):50-6. PubMed ID: 20963196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategic imperatives for globalization of industries in developing countries: an Indian pharmaceutical industry example.
    Srivastava R; Chandra A; Kumar G
    Health Mark Q; 2004; 22(1):57-69. PubMed ID: 15914384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues with regulatory pharmacovigilance in East European countries: the industry perspective.
    Hanzl-Dujmović I; Sulić-Milisić Z; Staresinić-Sernhorst I
    Toxicol Lett; 2007 Feb; 168(3):228-35. PubMed ID: 17161561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When Advisors' True Intentions Are in Question. How Do Bank Customers Cope with Uncertainty in Financial Consultancies?
    Mackinger B; Jonas E; Mühlberger C
    Front Psychol; 2017; 8():1112. PubMed ID: 28713314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. With the help of a foreign ally: biopharmaceutical innovation in India after TRIPS.
    Angeli F
    Health Policy Plan; 2014 May; 29(3):280-91. PubMed ID: 23558959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug discovery alliances in India--indications, targets, and new chemical entities.
    Differding E
    ChemMedChem; 2014 Jan; 9(1):43-60. PubMed ID: 24136820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of COVID-19 on Indian Pharmaceutical Industry and Way Forward.
    Jadhav NV; Singh N; Targhotra M; Chauhan MK
    Infect Disord Drug Targets; 2021; 21(4):484-494. PubMed ID: 32888279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical Science Liaisons (MSL) in Africa: a perspective.
    Koot D; McMaster A; Nel M; van Tonder A; Barret A; Naidoo P
    Pan Afr Med J; 2019; 33():313. PubMed ID: 31692862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open Innovation in Medical and Pharmaceutical Research: A Literature Landscape Analysis.
    Yeung AWK; Atanasov AG; Sheridan H; Klager E; Eibensteiner F; Völkl-Kernsock S; Kletecka-Pulker M; Willschke H; Schaden E
    Front Pharmacol; 2020; 11():587526. PubMed ID: 33519448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Industry Support of Medical Research: Important Opportunity or Treacherous Pitfall?
    Tierney WM; Meslin EM; Kroenke K
    J Gen Intern Med; 2016 Feb; 31(2):228-233. PubMed ID: 26307387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant drug development, regulation, and commercialization: an Indian industry perspective.
    Sahoo N; Manchikanti P
    BioDrugs; 2011 Apr; 25(2):105-13. PubMed ID: 21230010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The departmental advisor's effect on medical students' confidence when the advisor evaluates or recruits for their own program during the match.
    Miller JB; Koehn NN; Schaad DC; Crittenden RA; Oriol NE
    Teach Learn Med; 2004; 16(3):290-5. PubMed ID: 15388388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.